BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 5152441)

  • 1. [First experiences with the use of dopamine (hydroxytyramine) in cardiogenic shock].
    Döring D; Fleischmann HJ; Heunisch K; Köhler H; Trenckmann H
    Z Gesamte Inn Med; 1971 Dec; 26(24):759-63. PubMed ID: 5152441
    [No Abstract]   [Full Text] [Related]  

  • 2. [Glucagon in cardiogenic shock].
    De Ninno F; Celentano V; Giugliano F
    Minerva Anestesiol; 1971 May; 37(5):240-6. PubMed ID: 5110768
    [No Abstract]   [Full Text] [Related]  

  • 3. [Dopamine in patients with cardiogenic shock (author's transl)].
    Kikis D; Esser H; Trübestein G
    Med Klin; 1977 Jul; 72(28-29):1212-7. PubMed ID: 329088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine for cardiogenic shock.
    Karliner JS
    JAMA; 1973 Dec; 226(10):1217-8. PubMed ID: 4800497
    [No Abstract]   [Full Text] [Related]  

  • 5. [The use of dopamin in shock and heart failure (author's transl)].
    Aroński A; Kübler A; Sliwinski M; Paszkowska A
    Anaesthesist; 1978 Apr; 27(4):183-6. PubMed ID: 655365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hemodynamic study of dopamine used in chronic heart failures and in cardiogenic shock as a complication of acute myocardial infarct].
    Flammang D; Sebastien P; Bouvrain Y
    Ann Anesthesiol Fr; 1975 Dec; 16(9):669-72. PubMed ID: 5028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of dopamine in patients with cardiogenic shock.
    Holzer J; Karliner JS; O'Rourke RA; Pitt W; Ross J
    Am J Cardiol; 1973 Jul; 32(1):79-84. PubMed ID: 4713114
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cardiovascular effects of hydroxytyramine (dopamine) and its importance for the therapy of cardiogenic shock in heart infarct. 2. Experimental studies on hypodynamic hearts of dogs].
    Urbaszek W; Günther K; Trenckmann H; Döring D
    Z Gesamte Inn Med; 1970 Apr; 25(7):290-3. PubMed ID: 4398843
    [No Abstract]   [Full Text] [Related]  

  • 9. [Changes in some hemodynamic indices and the contractile state of the myocardium during infusion of dopamine in man].
    Di Segni E; Capestro F; Curzi G; Di Luzio V; Purcaro A; Soro A; Di Giuseppe F
    Boll Soc Ital Cardiol; 1971; 16(10):611-4. PubMed ID: 5147985
    [No Abstract]   [Full Text] [Related]  

  • 10. [Use of dopamine in the treatment of cardiogenic shock. Preliminary results].
    Chiche P; Baligadoo S
    Ann Anesthesiol Fr; 1975 Dec; 16(9):705-10. PubMed ID: 5034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of dopamine on cardiogenic and endotoxin experimental shock.
    Marchetti G; Longo T; Merlo L; Noseda V
    Eur Surg Res; 1973; 5(3):175-85. PubMed ID: 4584042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenesis of cardiogenic shock. I.
    Kones RJ
    N Y State J Med; 1973 Jun; 73(12):1662-70. PubMed ID: 4575582
    [No Abstract]   [Full Text] [Related]  

  • 13. Hemodynamic studies in acute myocardial infarction.
    Iwasaki T; Maeda K
    Jpn Circ J; 1974 Jun; 38(6):485-9. PubMed ID: 4436941
    [No Abstract]   [Full Text] [Related]  

  • 14. [Studies on the therapy of shock in acute myocardial infarct].
    Bravi A; Volpi G; Pupillo A; De Luca FM; Tuveri A
    Boll Soc Ital Cardiol; 1973; 18(2):139-46. PubMed ID: 4807052
    [No Abstract]   [Full Text] [Related]  

  • 15. Medical tretment and mortality in cardiogenic shock. Metaraminol compared with combined phentolamine and norepinephrine. Glucagon therapy.
    Takkunen J; Oilinki O; Huhti E; Vuopala U; Koivisto O
    Acta Med Scand; 1972 Sep; 192(3):165-70. PubMed ID: 5055261
    [No Abstract]   [Full Text] [Related]  

  • 16. [Central venous pressure and clinical findings in recent myocardial infarction].
    Buchwalsky R; Zeh E
    Z Kreislaufforsch; 1972 Feb; 61(2):124-34. PubMed ID: 5026176
    [No Abstract]   [Full Text] [Related]  

  • 17. [Our experience with the treatment of cardiogenic shock in recent myocardial infarction with dopamine and sodium nitroprusside].
    Korewicki J; Ostrzycki A; Opolski G
    Kardiol Pol; 1984; 27(5):345-51. PubMed ID: 6387246
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of irreversible heart decompensation and cardiogenic shock with glucagon].
    Bruni B
    Minerva Cardioangiol; 1972; 20(7):419-27. PubMed ID: 5050748
    [No Abstract]   [Full Text] [Related]  

  • 19. Dopamine--clinical uses of an endogenous catecholamine.
    Goldberg LI
    N Engl J Med; 1974 Oct; 291(14):707-10. PubMed ID: 4604342
    [No Abstract]   [Full Text] [Related]  

  • 20. [Left ventricular systolic intervals as indices of the pharmacological effect of intravenous administration of digoxin and their correlation with blood levels of the drug].
    De Bernardi A; Gastaldi L; Cottino AM; Rusconi O; Zardini P
    Boll Soc Ital Cardiol; 1975; 20(11):1505-11. PubMed ID: 1234449
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.